Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant burdens » significant burden (Expand Search), significant barriers (Expand Search), significant binding (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant burdens » significant burden (Expand Search), significant barriers (Expand Search), significant binding (Expand Search)
-
2261
-
2262
-
2263
-
2264
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
2265
-
2266
-
2267
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
2268
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2269
-
2270
-
2271
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2272
-
2273
-
2274
-
2275
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2276
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2277
-
2278
-
2279
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2280